Arsanis Inc (NASDAQ:ASNS) Sellers Covered 18.92% of Their Shorts

September 16, 2018 - By Elizabeth Bryant

The stock of Arsanis Inc (NASDAQ:ASNS) registered a decrease of 18.92% in short interest. ASNS’s total short interest was 118,300 shares in September as published by FINRA. Its down 18.92% from 145,900 shares, reported previously. With 183,600 shares average volume, it will take short sellers 1 days to cover their ASNS’s short positions. The short interest to Arsanis Inc’s float is 2.29%.

The stock decreased 2.21% or $0.04 during the last trading session, reaching $1.77. About 44,452 shares traded. Arsanis, Inc. (NASDAQ:ASNS) has 0.00% since September 16, 2017 and is . It has underperformed by 15.62% the S&P500.

Arsanis, Inc., a clinical-stage biopharmaceutical company, focuses on applying monoclonal antibody immunotherapies to address serious infectious diseases. The company has market cap of $25.34 million. The Company’s lead product candidate is ASN100, a first-in-class mAb therapeutic in Phase II clinical development for the prevention of staphylococcus aureus pneumonia. It currently has negative earnings. The company's preclinical pipeline comprises mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.

More news for Arsanis, Inc. (NASDAQ:ASNS) were recently published by: Nasdaq.com, which released: “New Research: Key Drivers of Growth for Harmonic, Astec Industries, Marlin Business Services, Arsanis, SunOpta, and …” on August 20, 2018. Seekingalpha.com‘s article titled: “Arsanis up 23%” and published on August 31, 2018 is yet another important article.

Arsanis, Inc. (NASDAQ:ASNS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.